Compare AstraZeneca plc (AZN) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Wells Fargo & Co — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Wells Fargo & Co trades at $87.48 (market cap $264.66B). The key difference: AstraZeneca plc and Wells Fargo & Co are close in size by market cap, and Wells Fargo & Co pays the higher dividend (2.29%). Which is the better fit depends on your goals.
| AZN | WFC | |
|---|---|---|
Market Cap | $248.14B | $264.66B |
Sector | Health | Financials |
52-Week High | $209.48 | $96.40 |
52-Week Low | $147.06 | $73.42 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | 2.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
